Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today unveiled Teva Rise, a global open innovation platform designed to harness the power of a variety of disruptive technologies including AI ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of ...

In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...

· In return for their investment in U.S. manufacturing, the administration would drop a proposed 100% tariffs on branded and patented drugs imported to the U.S. · Trump’s push for most-favored-nation ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

U.S. health authorities are considering how they might discourage or even ban vaccines that rely on a common ingredient to ...

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 welcomes project leaders, procurement specialists and technical professionals from the whole value chain. On 20-21 April in ...

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Despite many overseas drugmakers gaining some tariff clarity when the U.S. | Thanks to a new accord with the United States, ...